午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Changsha MOL Changes Biotechnology Co., Ltd.

Changsha MOL Changes Biotechnology Co., Ltd.

Main products: Peptide synthesis,Peptide modification,Protein and peptide labeling,Cellular response

Current Location: HOME >> Product
Product Categories
Changsha MOL Changes Biotechnology Co., Ltd.
Country: China
Tel:
Mobile: 19375158599
E-mail: info@molchanges.com
QQ:
Skype: Chat Now!
Address: Changsha Longping Bio-Industrial Park Provincial Research Center Factory
MOL Changes has unique technical capabilities in peptide synthesis, peptide modification, protein and peptide labeling, and cellular reactions. The company's technical staff comes from the fields of organic chemistry and biology, and the technical leadership consists of graduate students and PhDs. The company has mastered a wide range of peptide synthesis methods, including solid-phase peptide synthesis, liquid-phase peptide synthesis, combined liquid-solid peptide synthesis, reverse solid-phase peptide synthesis and microbial fermentation methods. microbial fermentation methods. We offer a wide range of synthetic R&D services for drug discovery, biological research and bioengineering, and provide scientists with viable pathways in the process of new drug development. The value of peptide synthesis we provide goes beyond long sequences and high purity, as we have unique techniques for solving complex and difficult peptide sequences, overcoming compatibility issues during peptide synthesis, and assisting our clients with a comprehensive optimization strategy for the research process. Our R&D, synthesis, purification, lyophilization, and testing are all done in sterile laboratories. Currently, we have set up research laboratories and branch offices in Changsha, Zhuzhou, and Hong Kong, and our customers are mainly from the United States, Canada, Russia, the United Kingdom, Australia, Sweden, Norway, and South Korea, which include biochemistry colleges, biochemical research institutes, medical research institutes, and bio-scientists. In the future, MOL Changes will continue to focus on technology research and development, with the aim of becoming a leading company in the field of single peptide products, and establishing a strong technological and cost advantage in the field, which will help our customers to occupy a dominant position in the market.
Product Name MF CAS Details
Necrofibrin, rat C32H47N7O9 123402-49-3 Details
RFRP-1(human) C67H101N19O14S 311309-25-8 Details
Parasin I (TFA) C82H154N34O24 219552-69-9 Details
P38 (411-425), M. leprae Details
NGR Peptide C20H36N10O8S2 651328-78-8 Details
Nuclear Export Signal, NES, PKI Details
NubO (68-75), Ndufa4 (68-75) Details
P62 (417-429), M. leprae Details
NPV Details
p3K, (Lys 58 Lys 60 Lys 63) Ea(52–68) Details
Murine CMV pp 89 (170-174) C29H41N7O7S Details
p34cdc2-derived peptide Details
pp60 c-src (521-533) C62H94N16O25 198754-34-6 Details
Palmitoyl Tripeptide-8 C37H61N9O4 936544-53-5 Details
Motilin, porcine C120H188N34O35S 52906-92-0 Details
Neurogranin (28-43) C78H134N28O19S 146554-17-8 Details
P69 (522-534), M. leprae Details
PRRS-RSAB-C Details
Prometryn C10H19N5S 7287-19-6 Details
Polistes Mastoparan C77H127N21O18 74129-19-4 Details
Pep 4A C63H117N21O16 Details
Sendai Virus Nucleoprotein (321-336) C85H110N20O23 133531-91-6 Details
Sendai Virus Nucleoprotein (SV9), 324-332 C46H64N10O12 Details
Prepro-Nerve Growth Factor (99-115) (mouse) C89H139N27O26 Details
R-JAG (188-206) R-Jagged-1(188-206), Notch Ligand Details
PLM derived peptide Details
Pseudin-2 C122H202N36O32 388602-02-6 Details
rec Acetyl-Eglin c C377H552N96O107 96380-69-7 Details
PHM-27/PHI, human C135H214N34O40S 118025-43-7 Details
proFIX18 Details
Pro-TGF-a Details
Locustachykinin I C43H63N13O11 Details
Hexa -Tyrosine C54H56N6O13 6934-38-9 Details
LHRH (lamprey III) C59H74N18O14 147859-97-0 Details
Lymphocyte Activating Pentapeptide C25H44N8O7 120484-65-3 Details
IELLQAR (8-branch MAPS) Selectin Binding Peptide C37H67N11O11 Details
MARCKS Protein (159-165) C45H72N10O9 Details
MAGE-3 Antigen (167-176), human C53H80N12O16S 178243-46-4 Details
KL-1 C53H90N16O18 Details
Invertebrate Tachykinin-I, OctTK-I Details
Sovateltide C86H117N17O27 142569-99-1 Details
Lys-Lys-IRS-1 (891-902) (dephosphorylated) (human) C73H114N18O22 172615-51-9 Details
Lytic Peptide, SB-37 Details
K-R-Q-H-P-G C30H51N13O8 Details
IP3R-derived Peptide Details
Intermedin-53 (human) 1140977-96-3 Details
Ketolide resistance Peptide MRFFV C34H50N8O6S Details
Mastoparan X C73H126N20O15S 72093-22-2 Details
LKRApYLG-NH2 C39H69N12O11P Details
MARCKS Protein (151-175) C147H243N41O31 134248-85-4 Details
Influenza HA (307-319) C69H118N18O19 528526-85-4 Details
LF 20 Consensus Peptide. Anthrax Related Lethal Factor C106H173N29O27S2 Details
Urechistachykinin I C50H85N19O14 Details
I-309 (human) Details
Leucomyosuppressin (lms) C59H84N16O15 Details
LMP1 (156-164),IAL Details
Leucopyrokinin (LPK) C42H66N12O12 Details
IRS1-derived peptide Details
OV-1, Sheep C105H188N34O21 326855-45-2 Details
LL-37 FK-13/LL-37 (17-29), Cationic Antimicrobial Protein 18 (150-162) (human), hCAP18 (150-162) AND LL17 - 29 C80H135N25O17 717919-68-1 Details
Urocortin II,human C196H340F3N63O56S 398001-88-2 Details
LMP2 (236-244) , RRR Details
LMP1,TDD Details
PAKtide Details
OV-2, Sheep Details
ForMothion C6H12NO4PS2 2540-82-1 Details
NES Topoisomerase II alpha (1017-1028) Details
p3K truncated, (Lys 58 Lys 60 Lys 63) Ea(54–68) Details
N-10 Region of TRAP C51H79N11O21S Details
Neo-Kyotorphin C28H47N9O9 Details
Neuropeptide F 136697-70-6 Details
Met-Lys-Bradykinin C61H94N18O13S 550-19-6 Details
HER2/neu (869-877) C49H75N9O20 Details
Rcramp Details
HPV-E7-N Details
Glycoprotein Hormone a (32-46) amide C78H128N24O20S Details
HPV-E6-N Details
Glycogen Synthase-derived peptide Details
Human Papillomavirus E7 protein (49 - 57) C52H77N15O13 Details
Hemoglobin (Hb) (64-76) C64H109N17O18 Details
G-P-R C13H24N6O4 Details
Leucopyrokinin (4-8); Pheromonotropic Pentapeptide C30H49N9O6 104191-78-8 Details
Intermedin (rat) 1816940-00-7 Details
Head activator (7-11) C32H54N6O6 Details
RSV M (187-195) Details
Myristoylated ADP-Ribosylation Factor 6, myr-ARF6 (2-13) Details
Myristoylated ADP-Ribosylation Factor 1, myr-ARF1 (2-17) Details
Morphine Modulating Peptide, C-Terminal Fragment C25H39N9O5 Details
MSP-1 (20-39), Merozoite Surface Peptide 1 Details
MKKp2 Details
LMP2 (419-427), TYG Details
LEAP-2 (38-77) (Human) Details
Kemptide Negative Control Details
P61 (343-355), M. leprae Details
MSP-1 P2, Malaria Merozoite Surface Peptide – 1 Details
PRRS-PQGAB-N Details
PDGFRtide Details
NPF C51H80N15O19P Details
KGF Receptor Peptide C114H174N30O42S 161338-76-7 Details
KK4A C74H138N22O19 Details
Product Total: Product Page:
24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53